Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.

scientific article published in July 1997

Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/PL00005026
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/pl00005026
P698PubMed publication ID9228188

P50authorG OlmosQ67934319
P2093author name stringJ A García-Sevilla
R Alemany
P433issue1
P921main subject2-imidazolineQ419555
P304page(s)39-47
P577publication date1997-07-01
P1433published inNaunyn-Schmiedeberg's Archives of PharmacologyQ1468251
P1476titleLabelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes
P478volume356

Reverse relations

cites work (P2860)
Q5341361990 years of monoamine oxidase: some progress and some confusion.
Q41444993A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus
Q43264170Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors
Q35027984Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Q88598558Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats
Q48404030Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors.
Q41835100Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine
Q45851009Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain
Q43670401Differential [(3)H]idazoxan and [(3)H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I(2) receptors in human postmortem frontal cortex.
Q48683741Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.
Q21090747Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection
Q28375258Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites
Q37294224Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site
Q48147582Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
Q46897079Investigation of antioxidant vitamins (A, E, C) and lipid peroxidation levels in rats injected N-(1,3-benzothiazol-2-yl)-N-(4,5-dihydro-1H-imidazol-2-yl) amine
Q48330142Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
Q41984937Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study
Q77676057[3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney

Search more.